I конгресс сердечно-сосудистых хирургов
                   и интервенционных радиологов
     Северо-Западного федерального округа

Чрескожные вмешательства vs коронарное шунтирование

Myocardial Revascularization: Surgery or Stenting? Myocardial Revascularization: Surgery or Stenting?
2007 г.
Sunny H Wong, MBChB; Song Wan, FRCS; Malcolm J Underwood, FRCS
Since the introduction of coronary artery bypass grafting (CABG) in 1967, and percutaneous transluminal coronary angioplasty (PTCA) 10 years later, several major clinical trials have compared the two therapeutic strategies, including the Bypass Angioplasty Revascularization Investigation (BARI) and the Coronary Angioplasty versus Bypass Revascularization Investigation (CABRI) trials.

Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis of data from the ARTS II, CARDia, ERACI III, and SYNTAX studies and systematic review of observation
2009 г.
Aaron M. From, MD; Firas J. Al Badarin, MBBS; Stephen S. Cha, MS; Charanjit S. Rihal, MD, FACC
Current ACC/AHA guidelines recommend that patients with multivessel coronary artery disease undergo revascularisation with coronary bypass grafting (CABG).

Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients
2009 г.
Umberto Benedetto, Giovanni Melina, Emiliano Angeloni, Simone Refice, Antonino Roscitano, Brenno Fiorani, Gian Domenico Di Nucci, Riccardo Sinatra
The two primary interventions for patients with multivessel coronary artery disease (MVD) are coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI).

2004 г.
Matthias Pfisterer, MD;
No prospective trial data are available on long-term outcomes in 80-year-old patients with chronic angina with regard to antiischemic therapy.

Outcome of Elderly Patients With Chronic Symptomatic Coronary Artery Disease With an Invasive vs Optimized Medical Treatment Strategy
2003 г.
Matthias Pfisterer, MD, FESC, FAHA; Peter Buser, MD; Stefan Osswald, MD; Urs Allemann, MD; Wolfgang Amann, MD; Walter Angehrn, MD; Eric Eeckhout, MD; Paul Erne, MD; Werner Estlinbaum, MD; Gabriela Kuster, MD; Tiziano Moccetti, MD; Barbara Naegeli, MD; Peter Rickenbacher, MD;
Whereas randomized clinical trials have shown that younger patients with chronic symptomatic coronary artery disease (CAD) benefit from revascularization regarding symptom relief and quality of life, no such data exist for patients older than 75 years.

Assessment of the SYNTAX score in the Syntax study
2009 г.
Patrick W. Serruys, MD, PhD; Yoshinobu Onuma, MD; Scot Garg, MD, MRCP; Giovanna Sarno, MD, PhD; Marcel van den Brand, MD, PhD; Arie-Pieter Kappetein, MD, PhD; Nic Van Dyck, RN; Michael Mack, MD; David Holmes, MD; Ted Feldman, MD; Marie-Claude Morice, MD; Antonio Colombo, MD; Eric Bass, PhD;Katrin Leadley, MD; Keith В Dawkins, MD; Gerrit-Anne van Es, PhD; Marie-Angele M. Morel, Bsc; Friedrich W. Mohr, MD
In previously published randomised trials including 2 and 3-vessel disease, patient selection or exclusion criteria resulted in only 2-12% of the patients screened being randomised.

Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 г.
Patrick W. Serruys, M.D., Ph.D., Marie-Claude Morice, M.D., A. Pieter Kappetein, M.D., Ph.D., Antonio Colombo, M.D., David R. Holmes, M.D., Michael J. Mack, M.D., Elisabeth Ståhle, M.D., Ted E. Feldman, M.D., Marcel van den Brand, M.D., Eric J. Bass, B.A., Nic Van Dyck, R.N., Katrin Leadley, M.D., Keith D. Dawkins, M.D., and Friedrich W. Mohr, M.D., Ph.D., for the SYNTAX Investigators
Coronary-artery bypass grafting (CABG) was introduced in 1968 and rapidly became the standard of care for symptomatic patients with coronary artery disease.

Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase
2006 г.
Arie Pieter Kappetein, Keith D. Dawkins, Friedrich W. Mohr, Marie Claude Morice, Michael J. Mack, Mary E. Russell, Jose Pomar, Patrick W.J.C. Serruys
Department of Thoracic Surgery, ErasmusMC
Coronary bypass surgery remains the standard of care for patients with three-vessel disease (3VD) and left main (LM) coronary arterydisease.

Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the arterial revascularisation therapies study part II (ARTS II)
2004 г.
P W Serruys, P A Lemos, B A van Hout, on behalf of the ARTS II Steering Committee and Investigators
In-stent restenosis and the need of repeat revascularisation remain the major limitations of coronary angioplasty for patients with multivessel disease.

Survival After Coronary Revascularization in the Elderly
2002 г.
Michelle M. Graham, MD; William A. Ghali, MD, MPH; Peter D. Faris, PhD; P. Diane Galbraith, BN; Colleen M. Norris, PhD; Merril L. Knudtson, MD; for the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investigators
Cardiovascular disease is a leading cause of morbidity and mortality in older people, and increasingly, elderly patients are referred for revascularization.